Selected research
Industry Research
Nanomedicine Manufacturing Services Industry Research Report 2026
Market perspective
The global Nanomedicine Manufacturing Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Nanomedicine Manufacturing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Nanomedicine Manufacturing Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Nanomedicine Manufacturing Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Nanomedicine Manufacturing Services include nanoComposix, Ardena Nanomedicines, Cytiva, Inside Therapeutics, Fortis Life Sciences, AstraZeneca, Ascendia Pharmaceuticals, Axolabs and AVANSA Technology & Services, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Nanomedicine Manufacturing Services market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Nanomedicine Manufacturing Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nanomedicine Manufacturing Services Market by Company
nanoComposix
Ardena Nanomedicines
Cytiva
Inside Therapeutics
Fortis Life Sciences
AstraZeneca
Ascendia Pharmaceuticals
Axolabs
AVANSA Technology & Services
MyBiotech
Nanochemazone
TechNanoIndia
Encapsula NanoSciences
STA Pharmaceutical Co. Ltd.
Nanomedicine Manufacturing Services Segment by Type
Nanocarrier Construction
Drug Production
Quality Testing
Process Development
Nanomedicine Manufacturing Services Segment by Application
Cancer
Cardiovascular Disease
Nervous System Disease
Infectious Disease
Others
Nanomedicine Manufacturing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanomedicine Manufacturing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nanomedicine Manufacturing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanomedicine Manufacturing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nanomedicine Manufacturing Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nanocarrier Construction
- Drug Production
- Quality Testing
- Process Development
Applications
- Cancer
- Cardiovascular Disease
- Nervous System Disease
- Infectious Disease
- Others
Companies covered
- nanoComposix
- Ardena Nanomedicines
- Cytiva
- Inside Therapeutics
- Fortis Life Sciences
- AstraZeneca
- Ascendia Pharmaceuticals
- Axolabs
- AVANSA Technology & Services
- MyBiotech
- Nanochemazone
- TechNanoIndia
- Encapsula NanoSciences
- STA Pharmaceutical Co. Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Nanomedicine Manufacturing Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Nanocarrier Construction
- 2.2.3 Drug Production
- 2.2.4 Quality Testing
- 2.2.5 Process Development
- 2.3 Nanomedicine Manufacturing Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cancer
- 2.3.3 Cardiovascular Disease
- 2.3.4 Nervous System Disease
- 2.3.5 Infectious Disease
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Nanomedicine Manufacturing Services Breakdown Data by Type
- 3.1 Global Nanomedicine Manufacturing Services Historic Market Size by Type (2021-2026)
- 3.2 Global Nanomedicine Manufacturing Services Forecasted Market Size by Type (2027-2032)
4 Nanomedicine Manufacturing Services Breakdown Data by Application
- 4.1 Global Nanomedicine Manufacturing Services Historic Market Size by Application (2021-2026)
- 4.2 Global Nanomedicine Manufacturing Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Nanomedicine Manufacturing Services Market Perspective (2021-2032)
- 5.2 Global Nanomedicine Manufacturing Services Growth Trends by Region
- 5.2.1 Global Nanomedicine Manufacturing Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Nanomedicine Manufacturing Services Historic Market Size by Region (2021-2026)
- 5.2.3 Nanomedicine Manufacturing Services Forecasted Market Size by Region (2027-2032)
- 5.3 Nanomedicine Manufacturing Services Market Dynamics
- 5.3.1 Nanomedicine Manufacturing Services Industry Trends
- 5.3.2 Nanomedicine Manufacturing Services Market Drivers
- 5.3.3 Nanomedicine Manufacturing Services Market Challenges
- 5.3.4 Nanomedicine Manufacturing Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Nanomedicine Manufacturing Services Players by Revenue
- 6.1.1 Global Top Nanomedicine Manufacturing Services Players by Revenue (2021-2026)
- 6.1.2 Global Nanomedicine Manufacturing Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Nanomedicine Manufacturing Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Nanomedicine Manufacturing Services Head Office and Area Served
- 6.4 Global Nanomedicine Manufacturing Services Players, Product Type & Application
- 6.5 Global Nanomedicine Manufacturing Services Manufacturers Established Date
- 6.6 Global Nanomedicine Manufacturing Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Nanomedicine Manufacturing Services Market Size (2021-2032)
- 7.2 North America Nanomedicine Manufacturing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Nanomedicine Manufacturing Services Market Size by Country (2021-2026)
- 7.4 North America Nanomedicine Manufacturing Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Nanomedicine Manufacturing Services Market Size (2021-2032)
- 8.2 Europe Nanomedicine Manufacturing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Nanomedicine Manufacturing Services Market Size by Country (2021-2026)
- 8.4 Europe Nanomedicine Manufacturing Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Nanomedicine Manufacturing Services Market Size (2021-2032)
- 9.2 Asia-Pacific Nanomedicine Manufacturing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Nanomedicine Manufacturing Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Nanomedicine Manufacturing Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Nanomedicine Manufacturing Services Market Size (2021-2032)
- 10.2 South America Nanomedicine Manufacturing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Nanomedicine Manufacturing Services Market Size by Country (2021-2026)
- 10.4 South America Nanomedicine Manufacturing Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Nanomedicine Manufacturing Services Market Size (2021-2032)
- 11.2 Middle East & Africa Nanomedicine Manufacturing Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Nanomedicine Manufacturing Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Nanomedicine Manufacturing Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 nanoComposix
- 12.1.1 nanoComposix Company Information
- 12.1.2 nanoComposix Business Overview
- 12.1.3 nanoComposix Revenue in Nanomedicine Manufacturing Services Business (2021-2026)
- 12.1.4 nanoComposix Nanomedicine Manufacturing Services Product Portfolio
- 12.1.5 nanoComposix Recent Developments
- 12.2 Ardena Nanomedicines
- 12.2.1 Ardena Nanomedicines Company Information
- 12.2.2 Ardena Nanomedicines Business Overview
- 12.2.3 Ardena Nanomedicines Revenue in Nanomedicine Manufacturing Services Business (2021-2026)
- 12.2.4 Ardena Nanomedicines Nanomedicine Manufacturing Services Product Portfolio
- 12.2.5 Ardena Nanomedicines Recent Developments
- 12.3 Cytiva
- 12.3.1 Cytiva Company Information
- 12.3.2 Cytiva Business Overview
- 12.3.3 Cytiva Revenue in Nanomedicine Manufacturing Services Business (2021-2026)
- 12.3.4 Cytiva Nanomedicine Manufacturing Services Product Portfolio
- 12.3.5 Cytiva Recent Developments
- 12.4 Inside Therapeutics
- 12.4.1 Inside Therapeutics Company Information
- 12.4.2 Inside Therapeutics Business Overview
- 12.4.3 Inside Therapeutics Revenue in Nanomedicine Manufacturing Services Business (2021-2026)
- 12.4.4 Inside Therapeutics Nanomedicine Manufacturing Services Product Portfolio
- 12.4.5 Inside Therapeutics Recent Developments
- 12.5 Fortis Life Sciences
- 12.5.1 Fortis Life Sciences Company Information
- 12.5.2 Fortis Life Sciences Business Overview
- 12.5.3 Fortis Life Sciences Revenue in Nanomedicine Manufacturing Services Business (2021-2026)
- 12.5.4 Fortis Life Sciences Nanomedicine Manufacturing Services Product Portfolio
- 12.5.5 Fortis Life Sciences Recent Developments
- 12.6 AstraZeneca
- 12.6.1 AstraZeneca Company Information
- 12.6.2 AstraZeneca Business Overview
- 12.6.3 AstraZeneca Revenue in Nanomedicine Manufacturing Services Business (2021-2026)
- 12.6.4 AstraZeneca Nanomedicine Manufacturing Services Product Portfolio
- 12.6.5 AstraZeneca Recent Developments
- 12.7 Ascendia Pharmaceuticals
- 12.7.1 Ascendia Pharmaceuticals Company Information
- 12.7.2 Ascendia Pharmaceuticals Business Overview
- 12.7.3 Ascendia Pharmaceuticals Revenue in Nanomedicine Manufacturing Services Business (2021-2026)
- 12.7.4 Ascendia Pharmaceuticals Nanomedicine Manufacturing Services Product Portfolio
- 12.7.5 Ascendia Pharmaceuticals Recent Developments
- 12.8 Axolabs
- 12.8.1 Axolabs Company Information
- 12.8.2 Axolabs Business Overview
- 12.8.3 Axolabs Revenue in Nanomedicine Manufacturing Services Business (2021-2026)
- 12.8.4 Axolabs Nanomedicine Manufacturing Services Product Portfolio
- 12.8.5 Axolabs Recent Developments
- 12.9 AVANSA Technology & Services
- 12.9.1 AVANSA Technology & Services Company Information
- 12.9.2 AVANSA Technology & Services Business Overview
- 12.9.3 AVANSA Technology & Services Revenue in Nanomedicine Manufacturing Services Business (2021-2026)
- 12.9.4 AVANSA Technology & Services Nanomedicine Manufacturing Services Product Portfolio
- 12.9.5 AVANSA Technology & Services Recent Developments
- 12.10 MyBiotech
- 12.10.1 MyBiotech Company Information
- 12.10.2 MyBiotech Business Overview
- 12.10.3 MyBiotech Revenue in Nanomedicine Manufacturing Services Business (2021-2026)
- 12.10.4 MyBiotech Nanomedicine Manufacturing Services Product Portfolio
- 12.10.5 MyBiotech Recent Developments
- 12.11 Nanochemazone
- 12.11.1 Nanochemazone Company Information
- 12.11.2 Nanochemazone Business Overview
- 12.11.3 Nanochemazone Revenue in Nanomedicine Manufacturing Services Business (2021-2026)
- 12.11.4 Nanochemazone Nanomedicine Manufacturing Services Product Portfolio
- 12.11.5 Nanochemazone Recent Developments
- 12.12 TechNanoIndia
- 12.12.1 TechNanoIndia Company Information
- 12.12.2 TechNanoIndia Business Overview
- 12.12.3 TechNanoIndia Revenue in Nanomedicine Manufacturing Services Business (2021-2026)
- 12.12.4 TechNanoIndia Nanomedicine Manufacturing Services Product Portfolio
- 12.12.5 TechNanoIndia Recent Developments
- 12.13 Encapsula NanoSciences
- 12.13.1 Encapsula NanoSciences Company Information
- 12.13.2 Encapsula NanoSciences Business Overview
- 12.13.3 Encapsula NanoSciences Revenue in Nanomedicine Manufacturing Services Business (2021-2026)
- 12.13.4 Encapsula NanoSciences Nanomedicine Manufacturing Services Product Portfolio
- 12.13.5 Encapsula NanoSciences Recent Developments
- 12.14 STA Pharmaceutical Co. Ltd.
- 12.14.1 STA Pharmaceutical Co. Ltd. Company Information
- 12.14.2 STA Pharmaceutical Co. Ltd. Business Overview
- 12.14.3 STA Pharmaceutical Co. Ltd. Revenue in Nanomedicine Manufacturing Services Business (2021-2026)
- 12.14.4 STA Pharmaceutical Co. Ltd. Nanomedicine Manufacturing Services Product Portfolio
- 12.14.5 STA Pharmaceutical Co. Ltd. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst